Actively Recruiting

Phase 4
Age: 6Years - 18Years
All Genders
NCT06186141

Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone

Led by Murdoch Childrens Research Institute · Updated on 2025-08-27

690

Participants Needed

1

Research Sites

157 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

POPCORN trial will compare the side effects and effectiveness of Morphine versus Oxycodone medication when prescribed for use as patient controlled analgesia (PCA) for pain relief for paediatric patients after-surgery. This trial is embedded into routine patient care using the hospital electronic medical record (EMR). Participants will be randomly assigned to either medication after they enrol in the study. The main questions the POPCORN trial aims to answer are: * 1\. Is there a difference in the usage of medication to treat nausea and vomiting for those who received oxycodone PCA versus morphine PCA for post-surgery pain relief? * 2\. Is there a difference in side effects or pain relief needed between the two groups? Study activities are as follows: * Participants enrolled to study during their pre-operative consultation * Participants are randomly assigned to morphine or oxycodone * No further study-specific activities expected from participant after enrolment and randomisation * Participant receives routine medical care as planned * Clinicians record assessments as per routine care in electronic medical record (EMR) * EMR data are extracted as trial data

CONDITIONS

Official Title

Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone

Who Can Participate

Age: 6Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Postoperative patients aged 6 to 18 years suitable for PCA
  • Patients deemed appropriate for morphine or oxycodone by their anesthetist
  • American Society of Anaesthesiologists (ASA) physical status score between 1 and 3
  • Informed consent provided by parent or legal guardian
Not Eligible

You will not qualify if you...

  • Allergy, hypersensitivity, or contraindication to morphine or oxycodone
  • Significant intellectual disability or physical incapacity preventing PCA use
  • ASA score of 4 or higher
  • Parent or legal guardian unwilling or unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Royal Children's Hospital

Melbourne, Victoria, Australia, 3052

Actively Recruiting

Loading map...

Research Team

J

Justine Adams

CONTACT

S

Suzette Sheppard

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here